Cost-effectiveness analysis of lopinavir, ritonavir, and nevirapine toward HIV AIDS patients as antiretroviral: a systematic review
AM Pratama, HR Pramestutie, KI Krisnadewi, H Pratiwi
Tidak tersedia
Tidak tersedia
0